Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on January 1, 2006

Papers In Press, published online ahead of print October 18, 2005
J. Lipid Res., doi:10.1194/jlr.M500205-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M500205-JLR200v1
47/1/99    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gormsen, L. C.
Right arrow Articles by Nielsen, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gormsen, L. C.
Right arrow Articles by Nielsen, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on May 19, 2005
Revised on October 11, 2005
Accepted on October 17, 2005

Measuring VLDL-triglycerides turnover in humans using ex-vivo prepared VLDL tracer

Lars C. Gormsen, Michael D. Jensen, and Soren Nielsen

Endocrine Research Unit, Mayo Clinic, Rochester, MN 55905

Corresponding Author: jensen.michael{at}mayo.edu

There has been more interest in Very-Low-Density-Lipoprotein (VLDL) triglyceride (TG) kinetics during the last decade. Unfortunately, robust measurement methods are elaborate and not readily available. Herein we describe a method utilizing unique, ex-vivo, labeling of fatty acid moiety of VLDL-TG followed by intravenous bolus infusion in the same person. We found that plasma disappearance of ex-vivo labeled VLDL-TG was comparable to in-vivo labeled VLDL-TG and that turnover rates can be safely estimated from log linear decay of VLDL-TG specific activity. We found minor labeling of plasma free fatty acid (FFA) (oleate) pool, which was largely attributed to co-infusion of free [14C]triolein; VLDL-TG did not contribute substantially to plasma FFA pool. The plasma decay curve of VLDL-TG was not affected by the presence of tracer in the FFA pool provided that the data from 2 hours after the VLDL tracer bolus infusion was used. The FFA contamination problem was circumvented by minor modification of the VLDL-TG tracer preparation. The approach we describe should expand the opportunity to study processes that cannot be assessed if the FFA precursor pool is labeled. This method for VLDL-TG tracer preparation can allow measurement of VLDL turnover, tissue uptake of VLDL-TG, and oxidation of VLDL-TG.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. P. Sorensen, L. C. Gormsen, and S. Nielsen
VLDL-TG kinetics: a dual isotope study for quantifying VLDL-TG pool size, production rates, and fractional oxidation in humans
Am J Physiol Endocrinol Metab, December 1, 2009; 297(6): E1324 - E1330.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. C. Gormsen, B. Nellemann, L. P. Sorensen, M. D. Jensen, J. S. Christiansen, and S. Nielsen
Impact of body composition on very-low-density lipoprotein-triglycerides kinetics
Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E165 - E173.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. H. Nelson, R. Basu, C. M. Johnson, R. A. Rizza, and J. M. Miles
Splanchnic Spillover of Extracellular Lipase Generated Fatty Acids in Overweight and Obese Humans
Diabetes, December 1, 2007; 56(12): 2878 - 2884.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. H. Nelson, D. S. Edgerton, R. Basu, J. C. Roesner, A. D. Cherrington, and J. M. Miles
Triglyceride Uptake and Lipoprotein Lipase-Generated Fatty Acid Spillover in the Splanchnic Bed of Dogs
Diabetes, July 1, 2007; 56(7): 1850 - 1855.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. B. Krag, L. C. Gormsen, Z. Guo, J. S. Christiansen, M. D. Jensen, S. Nielsen, and J. O. L. Jorgensen
Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E920 - E927.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. H. Nelson, A. Prasad, A. Lerman, and J. M. Miles
Myocardial Uptake of Circulating Triglycerides in Nondiabetic Patients With Heart Disease
Diabetes, February 1, 2007; 56(2): 527 - 530.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
L. C. Gormsen, M. D. Jensen, O. Schmitz, N. Moller, J. S. Christiansen, and S. Nielsen
Energy expenditure, insulin, and VLDL-triglyceride production in humans
J. Lipid Res., October 1, 2006; 47(10): 2325 - 2332.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement